Downregulation of the tyrosine degradation pathway extends Drosophila lifespan

  1. Andrey A Parkhitko  Is a corresponding author
  2. Divya Ramesh
  3. Lin Wang
  4. Dmitry Leshchiner
  5. Elizabeth Filine
  6. Richard Binari
  7. Abby L Olsen
  8. John M Asara
  9. Valentin Cracan
  10. Joshua D Rabinowitz
  11. Axel Brockmann
  12. Norbert Perrimon  Is a corresponding author
  1. Harvard Medical School, United States
  2. National Centre for Biological Sciences, India
  3. Lewis-Sigler Institute for Integrative Genomics, Princeton University, United States
  4. Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, United States
  5. Beth Israel Deaconess Medical Center, United States
  6. Scintillon Institute, United States
  7. Princeton University, United States

Abstract

Aging is characterized by extensive metabolic reprogramming. To identify metabolic pathways associated with aging, we analyzed age-dependent changes in the metabolomes of long-lived Drosophila melanogaster. Among the metabolites that changed, levels of tyrosine were increased with age in long-lived flies. We demonstrate that the levels of enzymes in the tyrosine degradation pathway increase with age in wild-type flies. Whole-body and neuronal-specific downregulation of enzymes in the tyrosine degradation pathway significantly extends Drosophila lifespan, causes alterations of metabolites associated with increased lifespan, and upregulates the levels of tyrosine-derived neuromediators. Moreover, feeding wild-type flies with tyrosine increased their lifespan. Mechanistically, we show that suppression of ETC complex I drives the upregulation of enzymes in the tyrosine degradation pathway, an effect that can be rescued by tigecycline, an FDA-approved drug that specifically suppresses mitochondrial translation. In addition, tyrosine supplementation partially rescued lifespan of flies with ETC complex I suppression. Altogether, our study highlights the tyrosine degradation pathway as a regulator of longevity.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Additional metabolomics data are available upon request.

The following previously published data sets were used

Article and author information

Author details

  1. Andrey A Parkhitko

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    For correspondence
    aparkhitko@genetics.med.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9852-8329
  2. Divya Ramesh

    Tata Institute of Fundamental Research, National Centre for Biological Sciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1387-7832
  3. Lin Wang

    Department of Chemistry, Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmitry Leshchiner

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Elizabeth Filine

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Richard Binari

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Abby L Olsen

    Department of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. John M Asara

    Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Valentin Cracan

    Department of Chemistry, Scintillon Institute, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Joshua D Rabinowitz

    Department of Chemistry, Princeton University, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Axel Brockmann

    Tata Institute of Fundamental Research, National Centre for Biological Sciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  12. Norbert Perrimon

    Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States
    For correspondence
    perrimon@receptor.med.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7542-472X

Funding

NIA (K99/R00 AG057792)

  • Andrey A Parkhitko

NIH (5P01CA120964)

  • Norbert Perrimon

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Parkhitko et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,820
    views
  • 523
    downloads
  • 30
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andrey A Parkhitko
  2. Divya Ramesh
  3. Lin Wang
  4. Dmitry Leshchiner
  5. Elizabeth Filine
  6. Richard Binari
  7. Abby L Olsen
  8. John M Asara
  9. Valentin Cracan
  10. Joshua D Rabinowitz
  11. Axel Brockmann
  12. Norbert Perrimon
(2020)
Downregulation of the tyrosine degradation pathway extends Drosophila lifespan
eLife 9:e58053.
https://doi.org/10.7554/eLife.58053

Share this article

https://doi.org/10.7554/eLife.58053

Further reading

    1. Genetics and Genomics
    Fan Zhang, Annie Lee ... Hong Xu
    Research Article

    Mitochondrial biogenesis requires the expression of genes encoded by both the nuclear and mitochondrial genomes. However, aside from a handful transcription factors regulating specific subsets of mitochondrial genes, the overall architecture of the transcriptional control of mitochondrial biogenesis remains to be elucidated. The mechanisms coordinating these two genomes are largely unknown. We performed a targeted RNAi screen in developing eyes with reduced mitochondrial DNA content, anticipating a synergistic disruption of tissue development due to impaired mitochondrial biogenesis and mitochondrial DNA (mtDNA) deficiency. Among 638 transcription factors annotated in the Drosophila genome, 77 were identified as potential regulators of mitochondrial biogenesis. Utilizing published ChIP-seq data of positive hits, we constructed a regulatory network revealing the logic of the transcription regulation of mitochondrial biogenesis. Multiple transcription factors in core layers had extensive connections, collectively governing the expression of nearly all mitochondrial genes, whereas factors sitting on the top layer may respond to cellular cues to modulate mitochondrial biogenesis through the underlying network. CG1603, a core component of the network, was found to be indispensable for the expression of most nuclear mitochondrial genes, including those required for mtDNA maintenance and gene expression, thus coordinating nuclear genome and mtDNA activities in mitochondrial biogenesis. Additional genetic analyses validated YL-1, a transcription factor upstream of CG1603 in the network, as a regulator controlling CG1603 expression and mitochondrial biogenesis.

    1. Genetics and Genomics
    Jongkeun Park, WonJong Choi ... Dongwan Hong
    Research Article

    An unprecedented amount of SARS-CoV-2 data has been accumulated compared with previous infectious diseases, enabling insights into its evolutionary process and more thorough analyses. This study investigates SARS-CoV-2 features as it evolved to evaluate its infectivity. We examined viral sequences and identified the polarity of amino acids in the receptor binding motif (RBM) region. We detected an increased frequency of amino acid substitutions to lysine (K) and arginine (R) in variants of concern (VOCs). As the virus evolved to Omicron, commonly occurring mutations became fixed components of the new viral sequence. Furthermore, at specific positions of VOCs, only one type of amino acid substitution and a notable absence of mutations at D467 were detected. We found that the binding affinity of SARS-CoV-2 lineages to the ACE2 receptor was impacted by amino acid substitutions. Based on our discoveries, we developed APESS, an evaluation model evaluating infectivity from biochemical and mutational properties. In silico evaluation using real-world sequences and in vitro viral entry assays validated the accuracy of APESS and our discoveries. Using Machine Learning, we predicted mutations that had the potential to become more prominent. We created AIVE, a web-based system, accessible at https://ai-ve.org to provide infectivity measurements of mutations entered by users. Ultimately, we established a clear link between specific viral properties and increased infectivity, enhancing our understanding of SARS-CoV-2 and enabling more accurate predictions of the virus.